DataMeds AI, Inc.
MEDS
Positions held
Your positionsMEDS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $9.63M | Enterprise value | $40.58M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.49 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | -77.2% | Earnings growth | — | Gross margin | -90.6% | Operating margin | -4.1% |
| Profit margin | 0.0% | ROE | — | ROA | -82.9% | Debt / equity | — |
| Current ratio | 0.14 | Free cash flow | $2.37M | Analyst recommendation | none | Mean target | — |
| 52w high | $73.00 | 52w low | $0.82 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8M | $1.6M | $1.7M | $3.0M | $7.8M | — |
| Op margin | -412.7% | -385.7% | -766.0% | -1047.1% | -70.6% | — |
| Net income | -$18.4M | -$7.7M | -$27.9M | -$34.3M | -$6.7M | — |
| Gross margin | 10.2% | 10.9% | -470.2% | 7.7% | 6.5% | — |
| Gross profit | $0.2M | $0.2M | -$7.9M | $0.2M | $0.5M | — |
| Operating income | -$7.3M | -$6.0M | -$12.8M | -$31.5M | -$5.5M | — |
- Revenue +14% vs prior quarter ($1.8M vs $1.6M).
- Gross margin 10.2% (was 10.9% prior quarter).
- Operating margin compressed to -412.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $23.3M | $18.1M | $0.0M | $32.8M |
| Op margin | -347.9% | -33.9% | — | -10.4% |
| Net income | -$101M | -$6.9M | -$2.9M | -$2.7M |
| Gross margin | -27.5% | 9.7% | — | 17.5% |
| Gross profit | -$6.4M | $1.8M | $0.0M | $5.7M |
| Operating income | -$81.2M | -$6.1M | -$2.9M | -$3.4M |
Headlines — watch
• [WARN · legal] DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
News
2026-10-01 · DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%
2026-10-01 · Top Premarket Gainers
2026-10-01 · DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
2026-09-28 · Axe Compute Just Sold Its Cancer Business to Become an AI Stock
2026-09-28 · Top Midday Gainers
2026-09-28 · DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy Services
2026-09-28 · DataMeds AI stock rises on health app launch
2026-09-28 · DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
2026-09-25 · DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
2026-09-18 · Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point
2026-09-18 · DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
2026-09-16 · Sector Update: Healthcare Stocks Edge Lower Late Afternoon
Price (daily)
Full chart · RSI · MACD · patterns